drugset / Trial / NCT00772265

Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects

NCT00772265

Phase 1 Completed 56 enrolled Wockhardt
RandomizedCrossoverQuadruple-blindHealth-services research

Summary

The aim of this trial is to demonstrate bioequivalence of Wosulin N to Novolin® N with regard to its total and to its maximum serum insulin concentrations.

Timeline

Start
2010-09
Primary completion
2011-03
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 0.4 iu/kg Subcutaneous
Subject Wosulin R Protein / enzyme biologic 0.4 iu/kg Subcutaneous

Indications